DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 176 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $768,000 | -46.7% | 38,094 | -1.3% | 0.00% | -20.0% |
| Q2 2021 | $1,440,000 | +7.2% | 38,582 | -26.6% | 0.01% | 0.0% |
| Q1 2021 | $1,343,000 | +12.3% | 52,534 | -3.3% | 0.01% | +25.0% |
| Q4 2020 | $1,196,000 | +71.1% | 54,303 | +39.8% | 0.00% | +33.3% |
| Q3 2020 | $699,000 | -30.7% | 38,847 | -2.2% | 0.00% | -40.0% |
| Q2 2020 | $1,009,000 | +73.7% | 39,730 | +25.6% | 0.01% | +66.7% |
| Q1 2020 | $581,000 | -18.6% | 31,629 | -2.4% | 0.00% | 0.0% |
| Q4 2019 | $714,000 | +52.2% | 32,420 | -0.8% | 0.00% | +50.0% |
| Q3 2019 | $469,000 | -9.6% | 32,693 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $519,000 | +3.4% | 32,921 | -4.0% | 0.00% | 0.0% |
| Q1 2019 | $502,000 | +32.5% | 34,298 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $379,000 | -17.6% | 35,409 | +17.6% | 0.00% | 0.0% |
| Q3 2018 | $460,000 | +29.9% | 30,118 | +4.1% | 0.00% | +100.0% |
| Q2 2018 | $354,000 | -99.2% | 28,932 | +227.0% | 0.00% | – |
| Q1 2016 | $47,000,000 | -55.2% | 8,847 | 0.0% | 0.00% | – |
| Q4 2015 | $105,000,000 | +143735.6% | 8,847 | -0.2% | 0.00% | – |
| Q3 2015 | $73,000 | -99.9% | 8,863 | +0.1% | 0.00% | – |
| Q2 2015 | $123,499,000 | +129.7% | 8,853 | +295.8% | 0.00% | – |
| Q1 2015 | $53,755,000 | +45.9% | 2,237 | 0.0% | 0.00% | – |
| Q4 2014 | $36,843,000 | +24.4% | 2,237 | -3.8% | 0.00% | – |
| Q3 2014 | $29,610,000 | -43.6% | 2,326 | -0.0% | 0.00% | – |
| Q2 2014 | $52,520,000 | – | 2,327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|